tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VNRX Stock Latest News

VolitionRx preparing reimbursement submission for Nu.Q cancer assays in France
The FlyVolitionRx preparing reimbursement submission for Nu.Q cancer assays in France
7d ago
VNRX
VolitionRx adds two laboratories providing its vet cancer test in U.S. and Asia
PremiumThe Fly
VolitionRx adds two laboratories providing its vet cancer test in U.S. and Asia
17d ago
VNRX
VolitionRx announces clinical data for Nu.Q Vet cancer test in cats
PremiumThe Fly
VolitionRx announces clinical data for Nu.Q Vet cancer test in cats
29d ago
VNRX
VolitionRX Announces CEO Departure Amid Cost Realignment
PremiumCompany Announcements
VolitionRX Announces CEO Departure Amid Cost Realignment
2M ago
8K
VNRX
VolitionRx announces new paper on Capture-Seq, achieves 180-fold enrichment
PremiumThe Fly
VolitionRx announces new paper on Capture-Seq, achieves 180-fold enrichment
2M ago
VNRX
VolitionRX Gains Momentum with Strategic Advancements in Sepsis and Cancer Diagnostics
PremiumRatingsVolitionRX Gains Momentum with Strategic Advancements in Sepsis and Cancer Diagnostics
2M ago
VNRX
VolitionRx downgraded to Hold from Buy at Maxim
Premium
The Fly
VolitionRx downgraded to Hold from Buy at Maxim
2M ago
VNRX
VolitionRx price target lowered to $1.50 from $2.50 at H.C. Wainwright
Premium
The Fly
VolitionRx price target lowered to $1.50 from $2.50 at H.C. Wainwright
3M ago
VNRX
VolitionRx Ltd. Earnings Call Highlights Growth and Partnerships
PremiumCompany Announcements
VolitionRx Ltd. Earnings Call Highlights Growth and Partnerships
3M ago
VNRX
VolitionRx Limited Reports Q3 2025 Financial Growth
PremiumCompany Announcements
VolitionRx Limited Reports Q3 2025 Financial Growth
3M ago
VNRX
VolitionRx reports Q3 revenue $600,000, consensus $715,590
PremiumThe Fly
VolitionRx reports Q3 revenue $600,000, consensus $715,590
3M ago
VNRX
VNRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
VNRX Earnings this Week: How Will it Perform?
3M ago
VNRX
VolitionRX Amends Underwriting Agreement for Stock Offering
PremiumCompany AnnouncementsVolitionRX Amends Underwriting Agreement for Stock Offering
3M ago
8K
VNRX
VolitionRx announces pricing of $6M offering of common stock, warrants
Premium
The Fly
VolitionRx announces pricing of $6M offering of common stock, warrants
4M ago
VNRX
VolitionRx announces offering of common stock and warrants, no amount given
Premium
The Fly
VolitionRx announces offering of common stock and warrants, no amount given
4M ago
VNRX
Strategic Partnerships and Growth Potential Justify Buy Rating for VolitionRX
PremiumRatings
Strategic Partnerships and Growth Potential Justify Buy Rating for VolitionRX
4M ago
VNRX
VolitionRx signs co-marketing and services agreement with Hologic
PremiumThe Fly
VolitionRx signs co-marketing and services agreement with Hologic
4M ago
HOLX
VNRX
VolitionRX’s Strategic Partnership and Growth Potential Drive Buy Rating
PremiumRatings
VolitionRX’s Strategic Partnership and Growth Potential Drive Buy Rating
5M ago
VNRX
VolitionRx signs first human out licensing deal for APS
PremiumThe Fly
VolitionRx signs first human out licensing deal for APS
5M ago
VNRX
VolitionRx Ltd. Earnings Call: Key Insights and Challenges
PremiumCompany AnnouncementsVolitionRx Ltd. Earnings Call: Key Insights and Challenges
5M ago
VNRX
VolitionRx Reports Q2 2025 Financial Results and Strategic Progress
Premium
Company Announcements
VolitionRx Reports Q2 2025 Financial Results and Strategic Progress
6M ago
VNRX
VolitionRx reports Q2 revenue $400K, consensus $375.72K
Premium
The Fly
VolitionRx reports Q2 revenue $400K, consensus $375.72K
6M ago
VNRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >